{
  "nct_id": "NCT99443561",
  "indication": "Type 2 Diabetes",
  "phase": "Phase 2",
  "sample_size": 50,
  "duration_weeks": 34,
  "dropout_rate": 0.33,
  "primary_endpoints": [
    "Fasting plasma glucose"
  ],
  "secondary_endpoints": [
    "Weight change",
    "HbA1c reduction"
  ],
  "blinding": "open-label",
  "control_arm": "placebo",
  "outcome_summary": "Study did not meet primary efficacy endpoints.",
  "success": false,
  "failure_reason": "Pharmacokinetic issues with drug exposure"
}